The Neuroscience 2023 annual gathering is the perfect platform that brings together a variety of academic and industrial specialists, including neurologists, neurosurgeons, scientists, academic scientists, and professionals in the diagnostic laboratory in a single platform to discuss the latest advancements and current research in the field.

Neuroscience 2023 focuses on the theme "Advancements and Breakthroughs in Neuroscience and Neurology". Our goal is to offer a top-notch curriculum that covers the whole spectrum of research and developments in neurology and neuroscience as well as to exchange cross-cultural experiences with various therapeutic modalities.

The Neuroscience 2023 conference will concentrate on creating keynote addresses of the highest caliber, speaker sessions, workshops, and a young researcher's forum that highlight technological advancements on a global scale and emphasize cutting-edge research and various tools for efficient disease treatment. This Neuroscience Conferences 2023 Summit will be the best place to learn about recent discoveries and new fields of ground-breaking work in neurology and neurological disorders.

We cordially welcome you to be a part of the event, and your presence will significantly enhance the occasion's value.

Neuroscience 2023 Highlights

200+ Participation
15+ Keynote Speakers
30+ Plenary Speakers
10+ Exhibitors
12 Innovative Educational Sessions
B2B Meetings

Why to Attend?

Neuroscience Conferences 2023 is a unique forum that aims to discuss and provide fresh ideas for researchers, regarding advancements in the field of Neurology. This Neuroscience Conferences 2023 is an opportunity to bring people from all around together to learn about the latest advancements in the field of Neurology and its related fields. Scientists and medical professionals can exchange ideas, discuss new discoveries, and plan future collaborative projects in small, intimate settings. This will lead to creating more impressive advancements in the field of Neurology and Neuroscience. Signs of this Conference include highly regarded speakers, cutting-edge techniques, and the most recent information on neurological disorders.

Target Audience

Neurologists
Neurosurgeon
Directors and Founders
Psychiatrists
Psychologists
University Professors
Research Scholars
University Students
Neurology Researchers
Clinical Neurologist
Chiropractors
Neuropsychologists
Neuroscientists
Health organizations
Business entrepreneurs
Pharmaceutical Industries
Manufacturing Medical Devices Companies

Major Scientific Sessions

Track 1: Psychiatry and Psychiatric Disorders

Psychiatry disorders are changes in the mental or behavioral pattern that causes significant distress or impairment of personal functioning. They may be persistent, relapsing and remitting, or occur as a single episode. Whereas Psychological syndrome or pattern occurs in an individual and is associated with present distress or disability or with a significantly increased risk of suffering death, pain, or disability.

Track 2: Depression and Anxiety Disorders

Anxiety is an orderly reaction caused due to stress. Anxiety disorders differ from normal feelings of Nervousness or Anxiousness. These are treatable various methods of treatment are available. Depression is also known as unipolar or major depressive disorder, is characterized by a persistent feeling of sadness or a lack of interest in outside stimuli.

Track 3: Paediatric Neurology

In the same way that pediatric neurology developed into a recognized specialty, because there was too much information and complexity for a general pediatrician or adult neurologist to master, the field has since continued to develop into a variety of subspecialties. These include epilepsy, neuromuscular disease, stroke, malformations, neonatal neurology, metabolic diseases, etc. that an overall pediatric neurologist cannot reasonably expect to have in-depth knowledge of. Thus, following a standard pediatric neurology residency, fellowship programming offers subspecialty expertise to some trainees, and many of these fellowships also incorporate research training.

Track 4: Neuroimmunology

The sciences of neurology, psychiatry, and immunology all contributed to the development of neuroimmunology as a unique discipline. Although neuroimmunologists initially focused on traditional neuroinflammatory disorders like multiple sclerosis and infections, there is compelling evidence that the immune response also contributes to age-related white matter disorders, epilepsy, neurodegenerative diseases, neuropsychiatric disorders, peripheral nervous system disorders, and neuro-oncological conditions. Technology advancements have considerably aided our understanding of how the immune system influences the neurological system during development and aging, and how such reactions result in disease as well as regeneration and repair.

Track 5: Neuroscience and Neurodegenerative Diseases

Neurodegenerative disorders are sicknesses that include the Degeneration of specific parts of the mind. They are, by a wide margin, probably the hardest infections to fix with incapacitating results. Parkinson's and Huntington's disease are among the most extreme and normal development problems. The scientific study of the Nervous system is called Neuroscience. It has a huge impact on the treatment and diagnosis of all nervous diseases.

Related Conferences: Neurology Conference | Advanced Neurology Conference | Neuroscience Conference | Neurological Disorders Conference | Neurosurgery Conference | Neuroscience Meetings | Parkinson’s Conference | Neuroscience Conferences | Neuroscience Events | Mental Health Conferences | Neuropsychiatry Conferences | Neurorehabilitation Conferences | Brain Disorders Conferences | Alzheimer’s Conferences | Dementia Conferences

Track 6: Neuropsychiatry

Neuropsychiatry is a synergistic interface between psychiatry and neurology that records mental disorders. The field of neuropsychiatry is locked in with understanding the connection between the brain, body, and its conduct. Treated as a sub-forte of Psychiatry, the normal cases begin from recognizable breakdowns. The mixture of Neuropsychiatry with nervous system specialist and Neurosurgeons give broad consideration and an effective setup for patients.

Related Conferences: Neurology Conference | Advanced Neurology Conference | Neuroscience Conference | Neurological Disorders Conference | Neurosurgery Conference | Neuroscience Meetings | Parkinson’s Conference | Neuroscience Conferences | Neuroscience Events | Mental Health Conferences | Neuropsychiatry Conferences | Neurorehabilitation Conferences | Brain Disorders Conferences | Alzheimer’s Conferences | Dementia Conferences

Track 7: Neurosurgery

Neurosurgery is the youngest surgical discipline that focuses on the diagnosis, treatment, and rehabilitation of neuro-related diseases and disorders. The history of neurosurgery dates back to the early 1990s. High-quality and life-sustaining treatments can be endowed for patients with advanced neurosurgical devices. Some of the common Neurosurgeries include craniotomy, Microsurgery, Oncological neurosurgery, neuro-endoscopy (endoscopic endonasal surgery), and stereotactic neurosurgery. Flow diversion devices, neuro-endovascular stents, liquid embolic, clot retrieval, and balloon catheters are innovative neurosurgical devices playing significant growth in the market. Due to its potential outcomes, global investors contribute more investments in R&D.

Related Conferences: Neurology Conference | Advanced Neurology Conference | Neuroscience Conference | Neurological Disorders Conference | Neurosurgery Conference | Neuroscience Meetings | Parkinson’s Conference | Neuroscience Conferences | Neuroscience Events | Mental Health Conferences | Neuropsychiatry Conferences | Neurorehabilitation Conferences | Brain Disorders Conferences | Alzheimer’s Conferences | Dementia Conferences

Track 8: Case Studies and Ethical issues

Case studies in Neuroscience and Neurology are crucial provenance of new ideas and hypotheses. The causes, symptoms and treatment, and possible outcomes are analyzed using the reports. This topic focuses on case study methodologies and advantages. Detailed Case studies most frequently describe people with rare, unique, and abnormal conditions. Framing the Neurological condition from the case report enhances new clinical inventions and therapeutics.

Related Conferences: Neurology Conference | Advanced Neurology Conference | Neuroscience Conference | Neurological Disorders Conference | Neurosurgery Conference | Neuroscience Meetings | Parkinson’s Conference | Neuroscience Conferences | Neuroscience Events | Mental Health Conferences | Neuropsychiatry Conferences | Neurorehabilitation Conferences | Brain Disorders Conferences | Alzheimer’s Conferences | Dementia Conferences

Track 9: Neurological Complications of COVID-19

While the most common clinical diagnosis for the COVID-19 pandemic is a respiratory disease, there is growing awareness of neurological manifestations. The COVID-19 pandemic is caused by extreme coronavirus 2 (SARS-CoV-2) acute respiratory syndrome and is of a magnitude not seen since the influenza pandemic of 1918. Based on information about other coronaviruses, particularly those that produced severe acute respiratory syndrome and epidemics of the centre East respiratory syndrome, it should be assumed that occurrences of CNS and peripheral systema nervosum disease brought on by SARS-CoV-2 are rare. For scientists, researchers, and young scholars to better understand the neurological side effects of COVID-19, Neuroscience 2023 offers a platform.

Track 10: Neuroimaging and pathology

All of clinical neuroscience has been transformed by neuroimaging, particularly how severe brain pathology may be identified in a live patient. The primary neuroimaging techniques for the pathological identification of acute and subacute traumatic injury in traumatic brain injury (TBI) are computed tomography (CT) and magnetic resonance imaging (MRI), with MRI best suited to identifying and quantifying the more chronic consequences. All neuroimaging findings of trauma-related pathology, however, are merely outward manifestations of the microscopic cellular and vascular illnesses that underlie all TBI.

Abstract Submission Guidelines

Abstracts for Oral, Video, and Poster presentations related to Neuroscience, Neurology, and other related topics are still being accepted by our Neuroscience 2023 Scientific Committee. The primary focus of the abstracts must concentrate on the above-mentioned sessions.

The duration of the scientific review process is 3–4 working days, and you will be notified of the abstract review status via email.

Note: There is a registration fee for attending the conference! It should be paid after the abstract acceptance notification.

Submit your abstract at the below-mentioned link and download the sample template for your easy reference.

Abstract Submission - https://www.longdom.com/neuroscience/abstract

Apply for the poster competition, young researcher award, and research excellence award at the following links.

YRF- https://www.longdom.com/neuroscience/young-researchers-award

Awards - https://www.longdom.com/neuroscience/awards

For the research excellence award, kindly write us via email about your interest in the nomination.

Market Analysis

Millions of people worldwide are affected by neurological illnesses. Stroke kills more than six million people per year; Almost 80% of these deaths occur in nations with poor or middle incomes. More than 50 million people worldwide suffer from epilepsy. With 7.7 million new cases each year, Alzheimer's disease is the most frequent cause of dementia, affecting 48 million individuals globally and maybe 60–70% of all cases. In the world, more than 10% of people suffer from anxiety. The most prevalent kind of dementia is Alzheimer's disease, according to World Information, a well-known pioneer in the provision of corporate information and analytics.

The market for neurological disorders was valued at $2.9 billion in 2016 and is anticipated to increase at a CAGR of 8% to reach $14.8 billion by 2026. The proportion of people who suffer from different neurological illnesses is typically decreased by the following factors: The town's 390,480 firms, of which 80.6 percent are involved in trade, transportation, and other services, 6.5 percent in construction, and 3.9 percent in business, make up the majority of the economy. The majority of salaried Parisians work in the 370,000 business services occupations that are located in the northwestern eighth, sixteenth, and seventeenth arrondissements. According to UN statistics, there are 47.5 million people who suffer from neurological illnesses, and 7.7 million new cases are reported every year.

Neurological illnesses are expected to affect 75.6 million people worldwide by 2030 and nearly quadruple to 145 million by 2050. In Neuroscience & Dementia, neurological illnesses account for 60–70% of dementia cases, with tube-shaped structural neurological disorders accounting for 200 cases globally. In the world, 47.5 million people suffer from neurological illnesses, and 7.7 million new cases are reported year, according to the United Nations agency. The estimated number of instances of neurological disorders worldwide by 2030 is 75.6 million, almost tripling to one hundred thirty-five million by 2050. Dementia and neurologic disorders account for 60–70% of all cases in neuroscience, with tube-shaped structures being the second most frequent form of dementia. Diseases of the nervous system cause two hundred cases.

Past Conference Reports

Neuroscience 2019

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations, and Exhibitors for making the Neuroscience 2019 Webinar the best ever!

Global Neuroscience and Dementia Research, hosted by the Longdom Conference was held during November 14-15, 2019 in Dubai, UAE based on the theme “Modern Techniques in Neuroscience Research "

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:
1- Nakieta Lankster, Psychologist, USA
2- Rozainee Khairudin, Universiti Kebangsaan, Malaysia
3- Reginald Dennis Gwisai, Bindura University of Science Education, Zimbabwe
4- Qian Jia, 1Beijing tian tan hospital, Capital medical university, China
5- Seinn M M Aye, Asia Royal Hospital, Yangon, Myanmar
For more details on our previous Event visit: https://www.longdom.com/neuroscience-2019

Neuroscience 2022

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations, and Exhibitors for making Neuroscience 2022 the best ever!

Global Neuroscience and Dementia Research, hosted by the Longdom Conference was held during November 14-15, 2022 in Dubai, UAE based on the theme “Modern Techniques in Neuroscience Research "

With the grand success of Neuroscience 2023, Longdom Conferences is proud to announce the “4th International Conference on Neuroscience and Neurology" to be held November 20-22, 2023 in London, UK

abstracts@longdom.com

finance@longdom.com

support@longdom.com

Speakers Interview

Neuroscience 2023 Highlights

Why to Attend?

Target Audience

Major Scientific Sessions

Abstract Submission Guidelines

Market Analysis

Past Conference Reports

Neuroscience 2019

Neuroscience 2022

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Scientists uncover a new role for blood-brain barrier in neuron function and damage

How the brain gathers threat cues and turns them into fear Findings could lead to treatments for fear-related disorders

Study reveals altered brain dynamics in those with unresponsive arousal syndrome, previously known as “vegetative state”, and in those with minimally conscious state.

Newsletter

About

Neuroscience and Neurology

Neuroscience 2023 Highlights

Why to Attend?

Target Audience

Major Scientific Sessions

Abstract Submission Guidelines

Market Analysis

Past Conference Reports

Neuroscience 2019

Neuroscience 2022

Scientists uncover a new role for blood-brain barrier in neuron function and damage

How the brain gathers threat cues and turns them into fear Findings could lead to treatments for fear-related disorders

Study reveals altered brain dynamics in those with unresponsive arousal syndrome, previously known as “vegetative state”, and in those with minimally conscious state.